Literature DB >> 31019704

Appropriateness of pancreatic resection in high-risk individuals for familial pancreatic ductal adenocarcinoma: a patient-level meta-analysis and proposition of the Beaujon score.

Louis de Mestier1, Marie Muller2, Jérôme Cros3, Marie-Pierre Vullierme4, Dewi Vernerey5, Frédérique Maire1, Safi Dokmak6, Vinciane Rebours1, Alain Sauvanet6, Philippe Lévy1, Pascal Hammel2.   

Abstract

Background: About 5% of pancreatic ductal adenocarcinomas are inherited due to a deleterious germline mutation detected in 20% or fewer families. Pancreatic screening in high-risk individuals is proposed to allow early surgical treatment of (pre)malignant lesions. The outcomes of pancreatic surgery in high-risk individuals have never been correctly explored.
Objectives: To evaluate surgical appropriateness and search for associated factors in high-risk individuals.
Methods: A patient-level meta-analysis was performed including studies published since 1999. Individual classification distinguished the highest risk imaging abnormality into low-risk or high-risk abnormality, and the highest pathological degree of malignancy of lesions into no/low malignant potential or potentially/frankly malignant. Surgical appropriateness was considered when potentially/frankly malignant lesions were resected.
Results: Thirteen out of 24 studies were selected, which reported 90 high-risk individuals operated on. Low-risk/high-risk abnormalities were preoperatively detected in 46.7%/53.3% of operated high-risk individuals, respectively. Surgical appropriateness was consistent in 38 (42.2%) high-risk individuals, including 20 pancreatic ductal adenocarcinomas (22.2%). Identification of high-risk abnormalities was strongly associated with surgical appropriateness at multivariate analysis (P = 0.001). We proposed a score and nomogram predictive of surgical appropriateness, including high-risk abnormalities, age and existence of deleterious germline mutation.
Conclusion: Overall, 42.2% of high-risk individuals underwent appropriate surgery. The proposed score might help selecting the best candidates among high-risk individuals for pancreatic resection.

Entities:  

Keywords:  Familial pancreatic carcinoma; cancer screening; hereditary neoplastic syndromes; pancreatic neoplasm; pancreatic surgery

Mesh:

Year:  2019        PMID: 31019704      PMCID: PMC6466755          DOI: 10.1177/2050640618824910

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  34 in total

1.  Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis.

Authors:  Sivesh K Kamarajah; William R Burns; Timothy L Frankel; Clifford S Cho; Hari Nathan
Journal:  Ann Surg Oncol       Date:  2017-02-17       Impact factor: 5.344

Review 2.  Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas.

Authors:  Masao Tanaka; Carlos Fernández-Del Castillo; Terumi Kamisawa; Jin Young Jang; Philippe Levy; Takao Ohtsuka; Roberto Salvia; Yasuhiro Shimizu; Minoru Tada; Christopher L Wolfgang
Journal:  Pancreatology       Date:  2017-07-13       Impact factor: 3.996

3.  Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study.

Authors:  Marcia Irene Canto; Michael Goggins; Ralph H Hruban; Gloria M Petersen; Francis M Giardiello; Charles Yeo; Elliott K Fishman; Kieran Brune; Jennifer Axilbund; Constance Griffin; Syed Ali; Jeffrey Richman; Sanjay Jagannath; Sergey V Kantsevoy; Anthony N Kalloo
Journal:  Clin Gastroenterol Hepatol       Date:  2006-05-06       Impact factor: 11.382

Review 4.  Screening for pancreatic cancer: why, how, and who?

Authors:  Katherine E Poruk; Matthew A Firpo; Douglas G Adler; Sean J Mulvihill
Journal:  Ann Surg       Date:  2013-01       Impact factor: 12.969

5.  Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.

Authors:  F Maire; P Hammel; B Terris; F Paye; J-Y Scoazec; C Cellier; M Barthet; D O'Toole; P Rufat; C Partensky; E Cuillerier; P Lévy; J Belghiti; P Ruszniewski
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

6.  The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer.

Authors:  J W Poley; I Kluijt; D J Gouma; F Harinck; A Wagner; C Aalfs; C H J van Eijck; A Cats; E J Kuipers; Y Nio; P Fockens; M J Bruno
Journal:  Am J Gastroenterol       Date:  2009-06-02       Impact factor: 10.864

7.  PanGen-Fam: Spanish registry of hereditary pancreatic cancer.

Authors:  E Mocci; C Guillen-Ponce; J Earl; M Marquez; J Solera; M-T Salazar-López; C Calcedo-Arnáiz; E Vázquez-Sequeiros; J Montans; M Muñoz-Beltrán; A Vicente-Bártulos; C González-Gordaliza; A Sanjuanbenito; C Guerrero; E Mendía; E Lisa; E Lobo; J C Martínez; F X Real; N Malats; A Carrato
Journal:  Eur J Cancer       Date:  2015-07-23       Impact factor: 9.162

Review 8.  Endoscopic ultrasonography for surveillance of individuals at high risk for pancreatic cancer.

Authors:  Gabriele Lami; Maria Rosa Biagini; Andrea Galli
Journal:  World J Gastrointest Endosc       Date:  2014-07-16

9.  Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.

Authors:  Hans Vasen; Isaura Ibrahim; Carmen Guillen Ponce; Emily P Slater; Elvira Matthäi; Alfredo Carrato; Julie Earl; Kristin Robbers; Anneke M van Mil; Thomas Potjer; Bert A Bonsing; Wouter H de Vos Tot Nederveen Cappel; Wilma Bergman; Martin Wasser; Hans Morreau; Günter Klöppel; Christoph Schicker; Martin Steinkamp; Jens Figiel; Irene Esposito; Evelina Mocci; Enrique Vazquez-Sequeiros; Alfonso Sanjuanbenito; Maria Muñoz-Beltran; José Montans; Peter Langer; Volker Fendrich; Detlef K Bartsch
Journal:  J Clin Oncol       Date:  2016-04-25       Impact factor: 44.544

10.  Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma.

Authors:  Koji Shindo; Jun Yu; Masaya Suenaga; Shahriar Fesharakizadeh; Christy Cho; Anne Macgregor-Das; Abdulrehman Siddiqui; P Dane Witmer; Koji Tamura; Tae Jun Song; Jose Alejandro Navarro Almario; Aaron Brant; Michael Borges; Madeline Ford; Thomas Barkley; Jin He; Matthew J Weiss; Christopher L Wolfgang; Nicholas J Roberts; Ralph H Hruban; Alison P Klein; Michael Goggins
Journal:  J Clin Oncol       Date:  2017-08-02       Impact factor: 44.544

View more
  2 in total

Review 1.  Role of endoscopic ultrasound in the screening and follow-up of high-risk individuals for familial pancreatic cancer.

Authors:  Diane Lorenzo; Vinciane Rebours; Frédérique Maire; Maxime Palazzo; Jean-Michel Gonzalez; Marie-Pierre Vullierme; Alain Aubert; Pascal Hammel; Philippe Lévy; Louis de Mestier
Journal:  World J Gastroenterol       Date:  2019-09-14       Impact factor: 5.742

2.  Risk stratification tools for branch-duct intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Alberto Balduzzi; Roberto Salvia; Matthias Löhr
Journal:  United European Gastroenterol J       Date:  2022-02-05       Impact factor: 4.623

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.